GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Accounts Payable

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Accounts Payable : ¥657 Mil (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Accounts Payable?

China Resources Double-Crane Pharmaceutical Co's Accounts Payable for the quarter that ended in Mar. 2024 was ¥657 Mil.

China Resources Double-Crane Pharmaceutical Co's quarterly Accounts Payable increased from Sep. 2023 (¥706 Mil) to Dec. 2023 (¥723 Mil) but then declined from Dec. 2023 (¥723 Mil) to Mar. 2024 (¥657 Mil).

China Resources Double-Crane Pharmaceutical Co's annual Accounts Payable declined from Dec. 2021 (¥847 Mil) to Dec. 2022 (¥750 Mil) and declined from Dec. 2022 (¥750 Mil) to Dec. 2023 (¥723 Mil).

China Resources Double-Crane Pharmaceutical Co Accounts Payable Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co Accounts Payable Chart

China Resources Double-Crane Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 690.76 848.05 847.40 750.39 722.51

China Resources Double-Crane Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 809.71 803.66 706.40 722.51 656.73

China Resources Double-Crane Pharmaceutical Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

China Resources Double-Crane Pharmaceutical Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Accounts Payable
Comparable Companies
SHSE:600380 SHSE:600329 SZSE:300601 SHSE:600535 SHSE:603707 SHSE:600521 SZSE:300142 SHSE:600867 SHSE:600129 SZSE:002262 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
N/A
Address
No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102
Website
http://www.dcpc.com
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines